• Something wrong with this record ?

The Superiority of Removable Contact Splints in the Healing of Diabetic Foot during Postoperative Care

V. Fejfarová, J. Pavlů, R. Bém, V. Wosková, M. Dubský, A. Němcová, A. Jirkovská, B. Sixta, K. Sutoris, F. Thieme, DG. Armstrong, E. Vrátná, J. Hazdrová, V. Lánská,

. 2019 ; 2019 (-) : 5945839. [pub] 20190915

Language English Country Great Britain

Document type Comparative Study, Journal Article, Observational Study

Objective: Off-loading is one of the crucial components of diabetic foot (DF) therapy. However, there remains a paucity of studies on the most suitable off-loading for DF patients under postoperative care. The aim of our study was to evaluate the effect of different protective off-loading devices on healing and postoperative complications in DF patients following limb preservation surgery. Methods: This observational study comprised 127 DF patients. All enrolled patients had undergone foot surgery and were off-loaded empirically as follows: wheelchair+removable contact splint (RCS) (group R: 29.2%), wheelchair only (group W: 48%), and wheelchair+removable prefabricated device (group WP: 22.8%). We compared the primary (e.g., the number of healed patients, healing time, and duration of antibiotic (ATB) therapy) and secondary outcomes (e.g., number of reamputations and number and duration of rehospitalizations) with regard to the operation regions across all study groups. Results: The lowest number of postoperative complications (number of reamputations: p = 0.028; rehospitalizations: p = 0.0085; and major amputations: p = 0.02) was in group R compared to groups W and WP. There was a strong trend toward a higher percentage of healed patients (78.4% vs. 55.7% and 65.5%; p = 0.068) over a shorter duration (13.7 vs. 16.5 and 20.3 weeks; p = 0.055) in the R group, as well. Furthermore, our subanalysis revealed better primary outcomes in patients operated in the midfoot and better secondary outcomes in patients after forefoot surgery-odds ratios favouring the R group included healing at 2.5 (95% CI, 1.04-6.15; p = 0.037), reamputations at 0.32 (95% CI, 0.12-0.84; p = 0.018), and rehospitalizations at 0.22 (95% CI, 0.08-0.58; p = 0.0013). Conclusions: This observational study suggests that removable contact splint combined with a wheelchair is better than a wheelchair with or without removable off-loading device for accelerating wound healing after surgical procedures; it also minimises overall postoperative complications, reducing the number of reamputations by up to 77% and the number of rehospitalizations by up to 66%.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023677
003      
CZ-PrNML
005      
20250507093313.0
007      
ta
008      
201125e20190915xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2019/5945839 $2 doi
035    __
$a (PubMed)31637262
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Fejfarová, Vladimíra $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
245    14
$a The Superiority of Removable Contact Splints in the Healing of Diabetic Foot during Postoperative Care / $c V. Fejfarová, J. Pavlů, R. Bém, V. Wosková, M. Dubský, A. Němcová, A. Jirkovská, B. Sixta, K. Sutoris, F. Thieme, DG. Armstrong, E. Vrátná, J. Hazdrová, V. Lánská,
520    9_
$a Objective: Off-loading is one of the crucial components of diabetic foot (DF) therapy. However, there remains a paucity of studies on the most suitable off-loading for DF patients under postoperative care. The aim of our study was to evaluate the effect of different protective off-loading devices on healing and postoperative complications in DF patients following limb preservation surgery. Methods: This observational study comprised 127 DF patients. All enrolled patients had undergone foot surgery and were off-loaded empirically as follows: wheelchair+removable contact splint (RCS) (group R: 29.2%), wheelchair only (group W: 48%), and wheelchair+removable prefabricated device (group WP: 22.8%). We compared the primary (e.g., the number of healed patients, healing time, and duration of antibiotic (ATB) therapy) and secondary outcomes (e.g., number of reamputations and number and duration of rehospitalizations) with regard to the operation regions across all study groups. Results: The lowest number of postoperative complications (number of reamputations: p = 0.028; rehospitalizations: p = 0.0085; and major amputations: p = 0.02) was in group R compared to groups W and WP. There was a strong trend toward a higher percentage of healed patients (78.4% vs. 55.7% and 65.5%; p = 0.068) over a shorter duration (13.7 vs. 16.5 and 20.3 weeks; p = 0.055) in the R group, as well. Furthermore, our subanalysis revealed better primary outcomes in patients operated in the midfoot and better secondary outcomes in patients after forefoot surgery-odds ratios favouring the R group included healing at 2.5 (95% CI, 1.04-6.15; p = 0.037), reamputations at 0.32 (95% CI, 0.12-0.84; p = 0.018), and rehospitalizations at 0.22 (95% CI, 0.08-0.58; p = 0.0013). Conclusions: This observational study suggests that removable contact splint combined with a wheelchair is better than a wheelchair with or without removable off-loading device for accelerating wound healing after surgical procedures; it also minimises overall postoperative complications, reducing the number of reamputations by up to 77% and the number of rehospitalizations by up to 66%.
650    _2
$a senioři $7 D000368
650    12
$a amputace $x škodlivé účinky $7 D000671
650    _2
$a antibakteriální látky $x aplikace a dávkování $7 D000900
650    12
$a odstranění implantátu $7 D020878
650    _2
$a diabetická noha $x patologie $x patofyziologie $x terapie $7 D017719
650    _2
$a design vybavení $7 D004867
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a délka pobytu $7 D007902
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a ortopedické výkony $x škodlivé účinky $7 D019637
650    _2
$a znovupřijetí pacienta $7 D010359
650    _2
$a pooperační péče $x přístrojové vybavení $7 D011182
650    _2
$a reoperace $7 D012086
650    _2
$a rizikové faktory $7 D012307
650    12
$a dlahy $x škodlivé účinky $7 D013165
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a zatížení muskuloskeletálního systému $7 D016474
650    _2
$a vozíky pro invalidy $7 D014910
650    12
$a hojení ran $7 D014945
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Pavlů, Jaroslav $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Bém, Robert $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Wosková, Veronika $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Dubský, Michal $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Němcová, Andrea $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0231185
700    1_
$a Jirkovská, Alexandra $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Sixta, Bedřich $u Department of Transplant Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Sutoris, Karol $u Department of Transplant Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Thieme, Filip $u Department of Transplant Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Armstrong, David G $u Southwestern Academic Limb Salvage Alliance (SALSA), University of Southern California (USC), Los Angeles, USA.
700    1_
$a Vrátná, Eliška $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Hazdrová, Jitka $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Lánská, Věra $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
773    0_
$w MED00181720 $t Journal of diabetes research $x 2314-6753 $g Roč. 2019 (20190915), s. 5945839
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31637262 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20250507093311 $b ABA008
999    __
$a ok $b bmc $g 1595996 $s 1114353
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 2019 $c - $d 5945839 $e 20190915 $i 2314-6753 $m Journal of diabetes research $n J Diabetes Res $x MED00181720
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...